Ginkgo Bioworks Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.53 | -$3.15 | -$3.33 |
| Q2 2024 | 1 | -$3.28 | -$2.92 | -$3.10 |
| Q3 2024 | 1 | -$2.89 | -$2.58 | -$2.73 |
| Q4 2024 | 3 | -$1.52 | -$1.48 | -$1.50 |
| Q1 2025 | 2 | -$1.63 | -$1.45 | -$1.54 |
| Q2 2025 | 1 | -$1.41 | -$1.26 | -$1.33 |
| Q3 2025 | 1 | -$1.26 | -$1.12 | -$1.19 |
| Q4 2025 | 1 | -$0.95 | -$0.84 | -$0.90 |
| Q1 2026 | 1 | -$1.28 | -$1.14 | -$1.21 |
| Q2 2026 | 1 | -$0.98 | -$0.88 | -$0.93 |
| Q3 2026 | 1 | -$0.66 | -$0.59 | -$0.62 |
| Q4 2026 | 1 | -$0.59 | -$0.53 | -$0.56 |
Ginkgo Bioworks Holdings, Inc. Earnings Date And Information
Ginkgo Bioworks Holdings, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-1.08 earnings per share for the quarter, topping analysts' consensus estimates of $-2.4 by $1.32. The company had revenue of 89.05 M for the quarter and had revenue of 251.46 M for the year. Ginkgo Bioworks Holdings, Inc. has generated $-18 earnings per share over the last year ($-18.37 diluted earnings per share) and currently has a price-to-earnings ratio of -0.58. Ginkgo Bioworks Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
Ginkgo Bioworks Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$2.40 | -$1.08 | 1.32 | $44.99 M | $89.05 M |
| 08/08/2024 | Q2 2024 | -$3.20 | -$4.23 | -1.03 | $43.14 M | $56.21 M |
| 05/09/2024 | Q1 2024 | -$0.08 | -$3.31 | -3.23 | $37.94 M | |
| 02/29/2024 | Q4 2023 | -$0.09 | $0.00 | $34.76 M | ||
| 11/08/2023 | Q3 2023 | -$0.09 | -$6.21 | -6.12 | $48.08 M | $55.43 M |
| 08/09/2023 | Q2 2023 | -$0.09 | -$3.59 | -3.5 | $71.50 M | $80.57 M |
| 05/10/2023 | Q1 2023 | -$0.09 | -$4.28 | -4.19 | $80.70 M | |
| 03/13/2023 | Q4 2022 | -$3.81 | $98.29 M | |||
| 11/14/2022 | Q3 2022 | -$0.25 | -$0.41 | -0.16 | $60.35 M | $66.40 M |
| 08/15/2022 | Q2 2022 | -$0.05 | -$0.41 | -0.36 | $78.83 M | $144.62 M |
| 05/16/2022 | Q1 2022 | -$0.01 | -$0.37 | -0.36 | $168.41 M | |
| 03/28/2022 | Q4 2021 | -$1.05 | $148.49 M | |||
| 11/15/2021 | Q3 2021 | -$0.04 | -$0.08 | -0.04 | $46.00 M | $77.61 M |
| 08/16/2021 | Q2 2021 | -$0.04 | $43.64 M | |||
| 05/24/2021 | Q1 2021 | -$0.05 | $44.10 M | |||
| 12/30/2020 | Q4 2020 | -$0.03 | $32.06 M | |||
| 09/29/2020 | Q3 2020 | -$0.02 | $13.30 M | |||
| 06/29/2020 | Q2 2020 | -$3.67 | $10.16 M | |||
| 03/30/2020 | Q1 2020 | -$3.20 | $21.13 M | |||
| 11/14/2022 | Q3 2001 | -$0.25 | -$0.00 | 0.25 | $66.40 M |
Ginkgo Bioworks Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Ginkgo Bioworks Holdings, Inc.'s earnings date?
Ginkgo Bioworks Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
Did Ginkgo Bioworks Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Ginkgo Bioworks Holdings, Inc. (:DNA) reported $-1.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.4 by $1.32.
-
How can I listen to Ginkgo Bioworks Holdings, Inc.'s earnings conference call?
The conference call for Ginkgo Bioworks Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Ginkgo Bioworks Holdings, Inc.'s conference call transcript?
The conference call transcript for Ginkgo Bioworks Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Ginkgo Bioworks Holdings, Inc. generate each year?
Ginkgo Bioworks Holdings, Inc. (:DNA) has a recorded annual revenue of $251.46 M.
-
How much profit does Ginkgo Bioworks Holdings, Inc. generate each year?
Ginkgo Bioworks Holdings, Inc. (:DNA) has a recorded net income of $251.46 M. Ginkgo Bioworks Holdings, Inc. has generated $-18.37 earnings per share over the last four quarters.
-
What is Ginkgo Bioworks Holdings, Inc.'s price-to-earnings ratio?
Ginkgo Bioworks Holdings, Inc. (:DNA) has a price-to-earnings ratio of -0.58 and price/earnings-to-growth ratio is -0.02.
